关于azelastine-fluticasone鼻喷雾的通用竞争和价格
Akash M Bhat1, Zachary M Soler2, Rodney J Schlosser2,3
1Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
International forum of allergy & rhinology
|August 30, 2024
概括
通用阿泽拉斯-流动 (AZ-FL) 在2020年开始供应,增加了医疗保险的使用,降低了成本. 然而,由于加价,高零售价格仍然存在.
科学领域:
- 药物经济学 药物经济学
- 医疗保健服务研究 医疗服务研究
- 药物政策 药物政策
背景情况:
- 阿泽拉斯-流动 (AZ-FL) 是一种用于过敏性鼻炎的混合鼻喷雾剂.
- 原始制造商的专利执法推迟了仿制药竞争到2020年.
研究的目的:
- 评估通用阿泽拉斯-弗卢蒂卡松可用性对医疗保险利用率和支出的影响.
- 分析通用AZ-FL.的零售价格趋势.
主要方法:
- 在通用AZ-FL推出之前和之后,对医疗保险利用和支出数据的分析.
- 检查通用AZ-FL.的零售价格数据.
主要成果:
- 医疗保险对AZ-FL的使用在通用推出后显著增加.
- 医疗保险对AZ-FL的总体支出在通用药物可用性之后下降.
- 尽管仿制药进入市场,但仿制药AZ-FL的零售价格仍然很高.
结论:
- 通用阿泽拉斯-流动 (AZ-FL) 进入医疗保险导致医疗保险的利用率增加和总体支出减少.
- 通用AZ-FL的持续高零售价格突出了制造商和药店加价的问题.
关键词:
迪米斯塔 (Dymista) 是一个过敏性过敏性过敏性过敏性一个zelastine一个zelastine专属性 独家性 独家性这种药物是fluticasone.一个通用的通用.标记标记是一个标记.patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent价格 价格 价格 价格 价格鼻炎是一种鼻炎.更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.6K
15:04Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
10.9K
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
01:19Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
01:27Upper Respiratory Drugs: Decongestants
175
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
175
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
01:16Drugs Used in Upper Respiratory Disorders: Overview
190
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
190